CADRE HOLDINGS INC (CDRE) Fundamental Analysis & Valuation

NYSE:CDRE • US12763L1052

Current stock price

30.51 USD
-0.81 (-2.59%)
At close:
30.5088 USD
0 (0%)
After Hours:

This CDRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CDRE Profitability Analysis

1.1 Basic Checks

  • CDRE had positive earnings in the past year.
  • In the past year CDRE had a positive cash flow from operations.
  • CDRE had positive earnings in each of the past 5 years.
  • CDRE had a positive operating cash flow in each of the past 5 years.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

1.2 Ratios

  • The Return On Assets of CDRE (5.73%) is better than 70.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.89%, CDRE is in the better half of the industry, outperforming 76.25% of the companies in the same industry.
  • The Return On Invested Capital of CDRE (7.75%) is better than 68.75% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CDRE is in line with the industry average of 9.30%.
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROIC 7.75%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

1.3 Margins

  • CDRE's Profit Margin of 7.23% is fine compared to the rest of the industry. CDRE outperforms 68.75% of its industry peers.
  • In the last couple of years the Profit Margin of CDRE has declined.
  • CDRE has a better Operating Margin (12.30%) than 76.25% of its industry peers.
  • In the last couple of years the Operating Margin of CDRE has declined.
  • The Gross Margin of CDRE (42.54%) is better than 81.25% of its industry peers.
  • CDRE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

5

2. CDRE Health Analysis

2.1 Basic Checks

  • CDRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CDRE has been increased compared to 1 year ago.
  • CDRE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CDRE has a worse debt to assets ratio.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • CDRE has an Altman-Z score of 3.31. This indicates that CDRE is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 3.31, CDRE perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
  • The Debt to FCF ratio of CDRE is 5.45, which is a neutral value as it means it would take CDRE, 5.45 years of fcf income to pay off all of its debts.
  • CDRE has a better Debt to FCF ratio (5.45) than 71.25% of its industry peers.
  • CDRE has a Debt/Equity ratio of 0.92. This is a neutral value indicating CDRE is somewhat dependend on debt financing.
  • CDRE has a Debt to Equity ratio of 0.92. This is in the lower half of the industry: CDRE underperforms 71.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Altman-Z 3.31
ROIC/WACC0.76
WACC10.18%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • CDRE has a Current Ratio of 3.50. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
  • CDRE has a better Current ratio (3.50) than 63.75% of its industry peers.
  • A Quick Ratio of 2.54 indicates that CDRE has no problem at all paying its short term obligations.
  • CDRE's Quick ratio of 2.54 is fine compared to the rest of the industry. CDRE outperforms 71.25% of its industry peers.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 2.54
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

6

3. CDRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 18.89% over the past year.
  • The Earnings Per Share has been decreasing by -1.75% on average over the past years.
  • CDRE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.53%.
  • CDRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.57% yearly.
EPS 1Y (TTM)18.89%
EPS 3Y9.72%
EPS 5Y-1.75%
EPS Q2Q%-15.62%
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%

3.2 Future

  • CDRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.60% yearly.
  • CDRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.28% yearly.
EPS Next Y15.92%
EPS Next 2Y18.38%
EPS Next 3Y20.6%
EPS Next 5YN/A
Revenue Next Year18.25%
Revenue Next 2Y12.43%
Revenue Next 3Y11.28%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. CDRE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 28.51 indicates a quite expensive valuation of CDRE.
  • Compared to the rest of the industry, the Price/Earnings ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 77.50% of the companies listed in the same industry.
  • CDRE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.95.
  • With a Price/Forward Earnings ratio of 24.60, CDRE is valued on the expensive side.
  • 81.25% of the companies in the same industry are more expensive than CDRE, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. CDRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 28.51
Fwd PE 24.6
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CDRE is valued cheaper than 82.50% of the companies in the same industry.
  • CDRE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CDRE is cheaper than 92.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.93
EV/EBITDA 15.91
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • CDRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CDRE may justify a higher PE ratio.
  • A more expensive valuation may be justified as CDRE's earnings are expected to grow with 20.60% in the coming years.
PEG (NY)1.79
PEG (5Y)N/A
EPS Next 2Y18.38%
EPS Next 3Y20.6%

4

5. CDRE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.31%, CDRE has a reasonable but not impressive dividend return.
  • The stock price of CDRE dropped by -29.75% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • CDRE's Dividend Yield is rather good when compared to the industry average which is at 0.35. CDRE pays more dividend than 90.00% of the companies in the same industry.
  • CDRE's Dividend Yield is slightly below the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

  • CDRE has been paying a dividend for over 5 years, so it has already some track record.
  • CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years4
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • CDRE pays out 35.00% of its income as dividend. This is a sustainable payout ratio.
DP35%
EPS Next 2Y18.38%
EPS Next 3Y20.6%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CDRE Fundamentals: All Metrics, Ratios and Statistics

CADRE HOLDINGS INC

NYSE:CDRE (4/20/2026, 8:04:00 PM)

After market: 30.5088 0 (0%)

30.51

-0.81 (-2.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-10
Earnings (Next)05-04
Inst Owners76.47%
Inst Owner Change0.31%
Ins Owners27.3%
Ins Owner Change-0.33%
Market Cap1.30B
Revenue(TTM)610.31M
Net Income(TTM)44.14M
Analysts80
Price Target45.9 (50.44%)
Short Float %6.37%
Short Ratio5.65
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.37
Dividend Growth(5Y)N/A
DP35%
Div Incr Years2
Div Non Decr Years4
Ex-Date01-30
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.17%
Min EPS beat(2)-34.15%
Max EPS beat(2)1.81%
EPS beat(4)3
Avg EPS beat(4)16.71%
Min EPS beat(4)-34.15%
Max EPS beat(4)87.91%
EPS beat(8)5
Avg EPS beat(8)8.5%
EPS beat(12)9
Avg EPS beat(12)18.19%
EPS beat(16)10
Avg EPS beat(16)13.36%
Revenue beat(2)0
Avg Revenue beat(2)-6.82%
Min Revenue beat(2)-10.38%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-2.22%
Min Revenue beat(4)-10.38%
Max Revenue beat(4)4.48%
Revenue beat(8)4
Avg Revenue beat(8)-2.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.99%
Revenue beat(16)11
Avg Revenue beat(16)-0.01%
PT rev (1m)-8.78%
PT rev (3m)-7.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60.27%
EPS NY rev (1m)-17.17%
EPS NY rev (3m)-11.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.28%
Valuation
Industry RankSector Rank
PE 28.51
Fwd PE 24.6
P/S 2.14
P/FCF 22.93
P/OCF 20.46
P/B 4.1
P/tB 60.88
EV/EBITDA 15.91
EPS(TTM)1.07
EY3.51%
EPS(NY)1.24
Fwd EY4.07%
FCF(TTM)1.33
FCFY4.36%
OCF(TTM)1.49
OCFY4.89%
SpS14.28
BVpS7.44
TBVpS0.5
PEG (NY)1.79
PEG (5Y)N/A
Graham Number13.3812 (-56.14%)
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROCE 11.28%
ROIC 7.75%
ROICexc 9.51%
ROICexgc 20.95%
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
FCFM 9.31%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
ROICexc(3y)12.43%
ROICexc(5y)12.27%
ROICexgc(3y)27.27%
ROICexgc(5y)26.53%
ROCE(3y)13.93%
ROCE(5y)14.36%
ROICexgc growth 3Y25.09%
ROICexgc growth 5Y-11.22%
ROICexc growth 3Y20.63%
ROICexc growth 5Y-11.53%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Debt/EBITDA 3.13
Cap/Depr 36.79%
Cap/Sales 1.12%
Interest Coverage 4.21
Cash Conversion 68%
Profit Quality 128.79%
Current Ratio 3.5
Quick Ratio 2.54
Altman-Z 3.31
F-Score6
WACC10.18%
ROIC/WACC0.76
Cap/Depr(3y)38.02%
Cap/Depr(5y)32.68%
Cap/Sales(3y)1.17%
Cap/Sales(5y)1.03%
Profit Quality(3y)124.37%
Profit Quality(5y)277.85%
High Growth Momentum
Growth
EPS 1Y (TTM)18.89%
EPS 3Y9.72%
EPS 5Y-1.75%
EPS Q2Q%-15.62%
EPS Next Y15.92%
EPS Next 2Y18.38%
EPS Next 3Y20.6%
EPS Next 5YN/A
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%
Revenue Next Year18.25%
Revenue Next 2Y12.43%
Revenue Next 3Y11.28%
Revenue Next 5YN/A
EBIT growth 1Y3.13%
EBIT growth 3Y52.65%
EBIT growth 5Y6.18%
EBIT Next Year84.01%
EBIT Next 3Y32.76%
EBIT Next 5YN/A
FCF growth 1Y117.74%
FCF growth 3Y10.69%
FCF growth 5Y6.91%
OCF growth 1Y100.48%
OCF growth 3Y11.14%
OCF growth 5Y7%

CADRE HOLDINGS INC / CDRE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CADRE HOLDINGS INC (CDRE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CDRE.


What is the valuation status for CDRE stock?

ChartMill assigns a valuation rating of 6 / 10 to CADRE HOLDINGS INC (CDRE). This can be considered as Fairly Valued.


What is the profitability of CDRE stock?

CADRE HOLDINGS INC (CDRE) has a profitability rating of 6 / 10.


What is the valuation of CADRE HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CADRE HOLDINGS INC (CDRE) is 28.51 and the Price/Book (PB) ratio is 4.1.


Can you provide the expected EPS growth for CDRE stock?

The Earnings per Share (EPS) of CADRE HOLDINGS INC (CDRE) is expected to grow by 15.92% in the next year.